TissueGen Enhances Intellectual Property Portfolio With New Patent for Self-Expanding Medical Device
April 29, 2014 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Apr 29, 2014) - TissueGen® Inc., developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic...
Transdermal Patch Delivery Technologies Will Create New Blockbuster Drugs
March 25, 2014 07:30 ET
|
Lux Research
BOSTON, MA--(Marketwired - Mar 25, 2014) - Driven by convergence with other platform-enhancing technologies and shifting demographics, transdermal delivery of drugs (through the skin) is poised for...
Expansion and Partnerships Fuel Strong Year for TissueGen in 2013
February 04, 2014 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Feb 4, 2014) - TissueGen® Inc., developer of a groundbreaking biodegradable fiber format for drug delivery, had a significant year in 2013 marked by...
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
December 03, 2013 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the...
Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Convoy Therapeutics, Inc.
June 19, 2013 08:30 ET
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwired - Jun 19, 2013) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Convoy Therapeutics, Inc. The...
MRI Interventions' ClearPoint(R) System Helps Advance Brain Cancer Clinical Trial of Investigational Gene Therapy Drug Toca 511, Demonstrates Benefits of MRI-Guided Drug Delivery
April 25, 2013 08:00 ET
|
ClearPoint Neuro, Inc.
IRVINE, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Intervention System is advancing the minimally-invasive...
TissueGen Announces ELUTE(TM) Biodegradable Drug-Loaded Fiber
April 09, 2013 10:00 ET
|
TissueGen Inc
DALLAS, TX--(Marketwired - Apr 9, 2013) - TissueGen® Inc., developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic...
TissueGen and Biomedical Structures Announce Availability of Breakthrough Drug Delivery Platform for Implantable Devices
February 12, 2013 10:00 ET
|
TissueGen Inc.
DALLAS, TX and WARWICK, RI--(Marketwire - Feb 12, 2013) - TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide...
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
November 15, 2012 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012
November 13, 2012 13:34 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...